Revenue (QQ4 2024): 368,005,439 CNY; YoY: -93.76%; QoQ: +37.60%. Gross Profit: 28,527,003 CNY; Gross Margin: 7.75%; YoY Gross Profit: -98.39%; QoQ Gross Profit: +243.21%. EBITDA: -92,575,982 CNY; EBITDARatio: -0.2516; Operating Income: -115,567,932 CNY; Operating Margin: -31.40%. Net Income: -120,269,758 CNY; Net Margin: -32.68%; EPS: -0.28; EPS Diluted: -0.28; Weighted Avg Shares: 379,651,762. Net cash from operating activities: -134,975,396 CNY; Free Cash Flow: -194,115,315 CNY; Cash at end of period: 199,254,000 CNY; Net Change in Cash: -222,818,291 CNY. Capex: -59,139,919 CNY; CFO/FCF dynamics reflect working capital deterioration (Accounts Receivables: -66,341,739 CNY; Change in Working Capital: -24,836,608 CNY). Balance sheet highlights: Total Assets: 1,438,339,429 CNY; Total Liabilities: 756,058,435 CNY; Total Equity: 682,280,994 CNY. Cash & equivalents: 199,254,000 CNY; Short-Term Debt: 280,419,206 CNY; Long-Term Debt: 87,721,300 CNY; Total Debt: 368,140,506 CNY; Net Debt: 168,886,506 CNY. Current ratio approximate 1.53x (Current Assets 1,019,639,905 CNY vs Current Liabilities 665,084,993 CNY).